Mostrando 2 resultados de: 2
CYP2D6 polymorphism in patients with eating disorders
ArticleAbstract: CYP2D6 polymorphism is associated with variability in drug response, endogenous metabolism (that is,Palabras claves:CYP2D6, Eating disorders, pharmacogenetics, Ultrarapid metabolizersAutores:Adrián LLerena, Agüera Z., Dorado P., Estivill X., Fernández‐aranda F., Gratacòs M., Penãs-Lledó E.M.Fuentes:scopusOrexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome
ArticleAbstract: Background and aims: Orexins/hypocretins are orexigenic peptides implicated in the regulation of feePalabras claves:anorexia nervosa, Orexin-A, Partial hospitalization, Sleep, treatment outcomeAutores:Baños R.M., Beckmann J.S., Botella C., Casanueva F.F., Crujeiras A.B., Custal N., Estivill X., Fernández-García J.C., Fernández-Real J.M., Fernández‐aranda F., Frühbeck G., Garrido-Sanchez L., Israel M., Menchón J.M., Murcia S.J., Ortega F.J., Riesco N., Rodríguez A., Roser Granero, Sánchez‐díaz I., Sauchelli S., Steiger H., Tàrrega S., Tinahones F.J., Torre R.d.l.Fuentes:scopus